Dynavax Technologies Corporation Cash from Financing TTM:

59.04M for Dec. 31, 2012
View Full Chart

Dynavax Technologies Corporation Cash from Financing TTM Chart

    Dynavax Technologies Corporation Historical Cash from Financing TTM Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 59.04M
    Sept. 30, 2012 140.27M
    June 30, 2012 144.13M
    March 31, 2012 92.75M
    Dec. 31, 2011 91.44M
    Sept. 30, 2011 67.75M
    June 30, 2011 65.08M
    March 31, 2011 87.65M
    Dec. 31, 2010 87.63M
    Sept. 30, 2010 63.98M
    June 30, 2010 64.16M
    March 31, 2010 22.94M
    Dec. 31, 2009 22.06M
    Sept. 30, 2009 2.351M
    June 30, 2009 -0.708M
    March 31, 2009 -0.712M
    Dec. 31, 2008 1.392M
       
    Sept. 30, 2008 3.392M
    June 30, 2008 7.719M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro

    About Cash From Financing (TTM)

    Definition: Cash from Financing

    Learn More

    Get data for

    DVAX Cash from Financing TTM Benchmarks

    Companies
    Anika Therapeutics -0.1059M
    MannKind Corporation 179.58M
    Celldex Therapeutics 142.35M

    DVAX Cash from Financing TTM Rankings

    Overall 88th percentile
    940 of 8007
    Sector 87th percentile
    87 of 685 in Healthcare
    Industry 83rd percentile
    40 of 248 in Biotechnology

    DVAX Cash from Financing TTM Range, Past 5 Years

    Minimum -0.7120M Mar 2009
    Maximum 144.13M Jun 2012
    Average 53.81M